FDA to Study DTC Risk Data
The Food and Drug Administration says it is concerned about how much risk information is disclosed to consumers in print ads and that the information is not usually in a consumer-friendly format. The agency plans to study how to improve the presentation of such information. One study will look at whether giving consumers more context—instead of a list of risks, for instance—will aid their understanding of a product's potential downside. Another will look at the usefulness of several different formats for presenting the data. Comments on the proposed testing will be accepted until mid-April.